Atara Biotherapeutics Inc (NASDAQ: ATRA) stock enjoyed a major increase of 11.8% on 10/7/25. The shares closed at $15.63. Moreover, exceptionally high trading volume at 219% of normal accompanied the advance. The stock has been exceptionally strong relative to the market over the last nine months and has risen 13.2% during the last week.
Current PriceTarget Research Rating
Atara Biotherapeutics is currently unrated.
Rating Review
The stock is currently unrated.
Be the first to comment